COST-EFFECTIVENESS OF 13-VALENT AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION RELATIVE TO 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN CANADA

被引：1
|
作者：
Whillans, F. [1 ]
Kwan, H. [1 ]
Strutton, D. R. [2 ]
Earnshaw, S. R. [3 ]
Farkouh, R. [3 ]
机构：
[1] Wyeth Pharmaceut, Markham, ON, Canada
[2] Wyeth Res, Collegeville, PA USA
[3] RTI Hlth Solut, Res Triangle Pk, NC USA
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75101-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A425 / A425
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of the 13-valent Pneumococcal Conjugate Vaccine in Children in Portugal
    Gouveia, Miguel
    Fiorentino, Francesca
    Jesus, Goncalo
    Costa, Joao
    Borges, Margarida
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (08) : 782 - 787
  • [42] COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN ADULTS IN PORTUGAL
    Alarcao, J.
    Fiorentino, F.
    Gouveia, M.
    Jesus, G.
    Costa, J.
    Borges, M.
    VALUE IN HEALTH, 2016, 19 (07) : A414 - A414
  • [43] DYNAMIC MODELING OF COST-EFFECTIVENESS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION AGAINST STREPTOCOCCUS PNEUMONIAE IN TAIWAN
    Chang, C. J.
    Wu, D. B. S.
    Fann, C. S. J.
    Wen, Y. W.
    Huang, Y. C.
    Wu, C. L.
    VALUE IN HEALTH, 2011, 14 (07) : A286 - A286
  • [44] COST-EFFECTIVENESS OF 2+1 DOSING OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE COMPARED WITH 2+1 DOSING OF 10-VALENT CONJUGATE VACCINE IN PREVENTING PNEUMOCOCCAL DISEASE IN CANADA
    Earnshaw, S.
    McDade, C.
    Zanotti, G.
    Farkouh, R. A.
    Strutton, D.
    VALUE IN HEALTH, 2011, 14 (07) : A275 - A275
  • [45] The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease
    Principi, Nicola
    Esposito, Susanna
    EXPERT REVIEW OF VACCINES, 2015, 14 (10) : 1359 - 1366
  • [46] Cost-effectiveness of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in The Netherlands
    Postma, M. J.
    Hubben, G. A. A.
    Bos, J. M.
    van der Ende, A.
    van Alphen, L.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2006, 16 : 52 - 53
  • [47] Cost-effectiveness analysis of 10-and 13-valent pneumococcal conjugate vaccines in Peru
    Mezones-Holguin, Edward
    Canelo-Aybar, Carlos
    Clark, Andrew David
    Janusz, Cara Bess
    Jauregui, Barbara
    Escobedo-Palza, Seimer
    Hernandez, Adrian V.
    Vega-Porras, Denhiking
    Gonzalez, Marco
    Fiestas, Fabian
    Toledo, Washington
    Michel, Fabiana
    Suarez, Victor J.
    VACCINE, 2015, 33 : A154 - A166
  • [48] Cost-effectiveness analysis of the 10-and 13-valent pneumococcal conjugate vaccines in Argentina
    Uruena, Analia
    Pippo, Tomas
    Sol Betelu, Maria
    Virgilio, Federico
    Giglio, Norberto
    Gentile, Angela
    Garcia Jimenez, Salvador
    Jauregui, Barbara
    Clark, Andrew D.
    Diosque, Maximo
    Vizzotti, Carla
    VACCINE, 2011, 29 (31) : 4963 - 4972
  • [49] Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Compared With 7-valent Pneumococcal Conjugate Vaccine Among Healthy Infants in China
    Zhu, Fengcai
    Hu, Yuemei
    Li, Jingxin
    Ye, Qiang
    Young, Mariano M., Jr.
    Zhou, Xin
    Chen, Zhangjing
    Yan, Bing
    Liang, John Z.
    Gruber, William C.
    Giardina, Peter C.
    Scott, Daniel A.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (09) : 999 - 1010
  • [50] 13-valent Pneumococcal Conjugate Vaccine in Older Children and Adolescents Either Previously Immunized With or Naive to 7-valent Pneumococcal Conjugate Vaccine
    Frenck, Robert, Jr.
    Thompson, Allison
    Senders, Shelly
    Harris-Ford, Laurie
    Sperling, Malcolm
    Patterson, Scott
    Devlin, Carmel
    Jansen, Kathrin U.
    Gruber, William C.
    Emini, Emilio A.
    Scott, Daniel A.
    Gurtman, Alejandra
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (02) : 183 - 189
12345